← SynDRA
ARQ-621
SynDRA canonical compound SYN0039853 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | KIF11 |
|---|
| Mechanism of action | kinesin-like spindle protein inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- kinesin-like spindle protein inhibitor
- KIF11 MODULATOR
Cross-references
Synonyms
- UNII-UU55190C8S
- ARQ621
- UU55190C8S
- (R)-N-(3-AMINOPROPYL)-3-CHLORO-N-(1-(7-CHLORO-4-OXO-3-(PHENYLAMINO)-3,4-DIHYDROQUINAZOLIN-2-YL)BUT-3-YN-1-YL)-2-FLUOROBENZAMIDE
- Benzamide, N-(3-aminopropyl)-3-chloro-N-[(1R)-1-[7-chloro-3,4-dihydro-4-oxo-3-(phenylamino)-2-quinazolinyl]-3-butyn-1-yl]-2-fluoro-
- SCHEMBL361201
- C28H24Cl2FN5O2
- DTXSID80148974
- EX-A857
- UPJSUQWHUVLLNW-XMMPIXPASA-N
- MolPort-035-789-699
- BCP28395
- 2122AH
- ZINC68203755
- s7355
- AKOS032945139
- SB19448
- NCGC00386362-01
- KB-74734
- ARQ 621 [WHO-DD]
- RefChem:114164
- Eg5 inhibitor ARQ 621
- DTXCID0071465
- EG5 KINESIN-RELATED MOTOR PROTEIN INHIBITOR ARQ 621
- MFCD25976786
- NSC-771644
- orb1300807
- SCHEMBL29479147
- SCHEMBL30136957
- VTB25339
- NSC771644
- CCG-270010
- AC-33009
- DA-61218
- HY-16062
- MS-30090
- CS-0006132
- SW219929-1
Look up ARQ-621 in the interactive SynDRA portal →